Formycon Reports the EC’s Approval of FYB203 (Biosimilar, Eylea) Under the Brand Names Ahzantive and Baiama
Shots: Formycon & Klinge Biopharma have reported the EC’s approval of FY...
Shots: Formycon & Klinge Biopharma have reported the EC’s approval of FY...
Shots: Bio-Thera & World Medicine entered into an exclusive license & comm...
Shots: The UK’s MHRA has approved Otulfi (SC & IV), biosimilar of J&...
Shots: Teva Pharmaceuticals International secured semi-exclusive marketing rights...
Shots: GlycoNex has reported a licensing agreement to develop SPD8, a biosimilar v...
Shots: Xbrane Biopharma has resubmitted the BLA for its biosimilar of Genentech&rs...
Incisive News in 3 Shots.
Modal body text goes here.